Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report)’s stock price dropped 17.3% on Monday . The company traded as low as $0.52 and last traded at $0.52. Approximately 2,000 shares were traded during trading, an increase of 28% from the average daily volume of 1,560 shares. The stock had previously closed at $0.62.
Avacta Group Stock Down 17.3 %
The firm’s fifty day moving average price is $0.63 and its 200-day moving average price is $0.72.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Further Reading
- Five stocks we like better than Avacta Group
- What Are Dividend Challengers?
- Finding Hidden Gems: Unconventional Penny Stock Investing
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Price Targets on NVIDIA Rise in Front of Earnings
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
